Design Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Design Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Design Therapeutics Inc
Rating: 1.75675
Author: Trendlyne DVM scores

about

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modify...

5.53 -0.11 (-1.95%)

28.83% Fall from 52W High

224.1K

XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

11.0 / 100

Technically Neutral

59.3 / 100

No estimates available

Design Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Design Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modify...

28.83% Fall from 52W High

SWOT Analysis

Design Therapeutics Inc Live Price Chart